Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis

被引：4
|
作者：
Selvaraj, Shailendra, V [1 ]
Bares, Sara H. [2 ]
Havens, Joshua P. [1 ,2 ]
机构：
[1] Univ Nebraska Med Ctr, Dept Pharm Practice, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Dept Internal Med, Infect Dis, Omaha, NE USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2020年 / 7卷 / 10期
关键词：
emtricitabine/tenofovir alafenamide; pre-exposure prophylaxis; weight gain; DISOPROXIL FUMARATE; DOUBLE-BLIND; TENOFOVIR;
D O I：
10.1093/ofid/ofaa454
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Tenofovir alafenamide fumarate loaded long-acting microsphere for HIV pre-exposure prophylaxis
    Pawar, Manoj A.
    Abadi, Leila Fotooh
    Rojekar, Satish, V
    Yawalkar, Ankita N.
    Kulkarni, Smita S.
    Vavia, Pradeep R.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 87
  • [32] The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis
    Keller, Samuel B.
    Smith, Davey M.
    AIDS, 2011, 25 (18) : 2308 - 2310
  • [33] Public health significance of human immunodeficiency virus pre-exposure and post-exposure prophylaxis
    Xu, Jun-Jie
    Shang, Hong
    CHINESE MEDICAL JOURNAL, 2020, 133 (23) : 2773 - 2774
  • [34] Public health significance of human immunodeficiency virus pre-exposure and post-exposure prophylaxis
    Xu Jun-Jie
    Shang Hong
    中华医学杂志英文版, 2020, 133 (23) : 2773 - 2774
  • [35] No observed bidirectional effect between tenofovir diphosphate concentrations and gender-affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis
    Patel, Nimish
    Morris, Sheldon
    Burke, Leah
    Chow, Karen
    Pacheco, Deedee
    Anderson, Peter
    Stancyzk, Frank
    Blumenthal, Jill
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) : 2360 - 2365
  • [36] HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION AND USE OF PRE-EXPOSURE PROPHYLAXIS (PREP) IN ADOLESCENTS
    Shadianloo, Shervin
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S113 - S114
  • [37] Linking Emergency Department Patients at Risk for Human Immunodeficiency Virus to Pre-Exposure Prophylaxis
    Mahal, J. J.
    Seu, R.
    Deccy, S.
    Rodriguez, G.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S78 - S78
  • [38] Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
    Fulcher, Jennifer A.
    Li, Fan
    Cook, Ryan R.
    Zabih, Sara
    Louie, Alexander
    Okochi, Hideaki
    Tobin, Nicole H.
    Gandhi, Monica
    Shoptaw, Steven
    Gorbach, Pamina M.
    Aldrovandi, Grace M.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (11):
  • [39] Linking emergency department patients at risk for human immunodeficiency virus to pre-exposure prophylaxis
    Mahal, Jacqueline
    Deccy, Stephanie
    Seu, Rie
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 54 : 87 - 90
  • [40] Phase 3 randomized, controlled DISCOVER study of daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP): week 96 results
    Ruane, P. J.
    Clarke, A.
    Post, F. A.
    Schembri, G.
    Jessen, H.
    Trottier, B.
    Bergin, C.
    Molina, J-M
    Wong, P.
    Ebrahimi, R.
    Brainard, D. M.
    Osinusi, A.
    Das, M.
    McCallister, S.
    HIV MEDICINE, 2019, 20 : 95 - 96
12345